EJNMMI Research

Table 2 Mass, activity and uptake in the tumour determined from the biodistribution (bio) and imaging (im) studies and their relative percentage differences (diff), and delivered (¹¹¹In) and extrapolated (⁹⁰Y) tumour absorbed doses per injected activity (D/A) for the six mice included in the study

From: Pre-clinical quantitative imaging and mouse-specific dosimetry for ¹¹¹In-labelled radiotracers

Mouse no.	Mass (mg)		Diff (%)	Activity (MBq)		Diff (%)	%IA/g		Diff (%)	D/A (cGy/MBq)
Mouse no.	bio	im	Diff (%)	bio	im	Diff (%)	bio	im	Diff (%)	¹¹¹In	⁹⁰Y
M1	100	152	52	0.108	0.088	–18	47	25	–46	36	441
M2	66	92	40	0.079	0.065	–18	51	29	–42	44	559
M3	59	61	3	0.041	0.041	–2	34	32	–6	52	572
M4	215	264	23	0.335	0.264	–21	49	31	–36	52	725
M5	41	28	–31	0.015	0.011	–21	33	37	14	65	745
M6	232	256	10	0.144	0.124	–14	66	51	–23	69	950

%IA/g was calculated at 96 h for M1–M4 and 197 h for M5 and M6

Back to article page